Consistent with this hypothesis, a study performed in gliomas showed that decitabine-mediated proliferation arrest can be blocked by silencing of DNMT1, and overexpression of TERT correlated with an increase in DNMT1 levels, which improved decitabine sensitivity in the meanwhile [106]. The gene discussed is DNMT1; the disease is glioma.